Great Lakes Advisors LLC Sells 99 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Great Lakes Advisors LLC decreased its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 12.7% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 679 shares of the biotechnology company’s stock after selling 99 shares during the period. Great Lakes Advisors LLC’s holdings in Axon Enterprise were worth $404,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in AXON. Geode Capital Management LLC increased its position in Axon Enterprise by 2.0% during the 3rd quarter. Geode Capital Management LLC now owns 1,782,828 shares of the biotechnology company’s stock valued at $710,103,000 after buying an additional 35,320 shares in the last quarter. Westfield Capital Management Co. LP raised its position in shares of Axon Enterprise by 12.2% in the 3rd quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock worth $469,661,000 after purchasing an additional 127,769 shares during the last quarter. Champlain Investment Partners LLC boosted its stake in Axon Enterprise by 13.9% in the 3rd quarter. Champlain Investment Partners LLC now owns 682,420 shares of the biotechnology company’s stock worth $272,695,000 after purchasing an additional 83,265 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in Axon Enterprise by 1.6% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 561,263 shares of the biotechnology company’s stock valued at $224,281,000 after purchasing an additional 9,090 shares during the last quarter. Finally, Groupama Asset Managment bought a new stake in Axon Enterprise during the 3rd quarter valued at about $200,000. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Axon Enterprise Stock Performance

Shares of NASDAQ AXON opened at $556.26 on Monday. Axon Enterprise, Inc. has a 12-month low of $273.52 and a 12-month high of $715.99. The firm has a market capitalization of $42.62 billion, a price-to-earnings ratio of 143.74, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The firm has a 50 day moving average of $593.42 and a 200 day moving average of $536.68.

Insider Transactions at Axon Enterprise

In related news, insider Jeffrey C. Kunins sold 1,370 shares of Axon Enterprise stock in a transaction on Tuesday, December 17th. The stock was sold at an average price of $639.14, for a total transaction of $875,621.80. Following the transaction, the insider now directly owns 125,950 shares in the company, valued at approximately $80,499,683. The trade was a 1.08 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the company’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the sale, the director now owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 4,146 shares of company stock worth $2,623,157 in the last 90 days. 6.10% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on AXON shares. Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and increased their price target for the company from $500.00 to $700.00 in a report on Tuesday, December 3rd. JMP Securities reissued an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Barclays reaffirmed a “hold” rating on shares of Axon Enterprise in a report on Monday, March 10th. Craig Hallum downgraded Axon Enterprise from a “buy” rating to a “cautious” rating in a report on Monday, March 10th. Finally, Northcoast Research cut shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 19th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and eleven have issued a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $604.67.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.